Clinical Trial Update: MBM-01 (Tempol) for the Treatment of Ataxia Telangiectasia [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for MBM-01 (Tempol) in Ataxia Telangiectasia (including children).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ataxia Telangiectasia in Children
• Ataxia-telangiectasia

Drugs mentioned

• MBM-01 (Tempol)

Snippet

Sponsor: Matrix Biomed, Inc. | Conditions: Ataxia Telangiectasia Louis-Bar, Ataxia Telangiectasia in Children | Phase 2 | Status: UNKNOWN